Home LiteratureArticle Details
PMID: 10468550 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The maximal affinity of ligands.

Proceedings of the National Academy of Sciences of the United States of America ·Vol. 96 ·No. 18 ·1999-08-31 ·Pages 9997-10002

Kuntz ID, Chen K, Sharp KA, Kollman PA

Abstract

We explore the question of what are the best ligands for macromolecular targets. A survey of experimental data on a large number of the strongest-binding ligands indicates that the free energy of binding increases with the number of nonhydrogen atoms with an initial slope of approximately -1.5 kcal/mol (1 cal = 4.18 J) per atom. For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative molecular mass. This nonlinearity is largely ascribed to nonthermodynamic factors. An analysis of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands. Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.

MeSH Terms
Binding Sites Calorimetry Enzymes/chemistry,metabolism Hydrogen Bonding Kinetics Ligands Models, Theoretical Proteins/chemistry,metabolism Thermodynamics
Chemicals
Enzymes Ligands Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kuntz I D
Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143-0446, USA. kuntz@cgl.ucsf.edu
Chen K
Sharp K A
Kollman P A
References (39)
39 references, click to expand
  1. Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range.
    Biochemistry. 1991 Aug 20;30(33):8165-70 PMID: 1868091
  2. Enzyme catalysis: not different, just better.
    Nature. 1991 Mar 14;350(6314):121-4 PMID: 2005961
  3. Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects.
    Science. 1991 Apr 5;252(5002):106-9 PMID: 2011744
  4. The meaning of hydrophobicity.
    Science. 1990 Oct 12;250(4978):297-8 PMID: 2218535
  5. Comparative affinities of the epimeric reaction-intermediate analogs 2- and 4-carboxy-D-arabinitol 1,5-bisphosphate for spinach ribulose 1,5-bisphosphate carboxylase.
    J Biol Chem. 1988 Mar 25;263(9):4145-50 PMID: 3346241
  6. Protein densities.
    Int J Pept Protein Res. 1979 Feb;13(2):223-8 PMID: 429098
  7. The thermodynamics of absorption of xenon by myoglobin.
    J Phys Chem. 1970 May 28;74(11):2341-4 PMID: 5445459
  8. Functional group contributions to drug-receptor interactions.
    J Med Chem. 1984 Dec;27(12):1648-57 PMID: 6094812
  9. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site.
    J Med Chem. 1995 Jan 20;38(2):305-17 PMID: 7830273
  10. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site.
    Proteins. 1994 Jul;19(3):199-221 PMID: 7937734
  11. 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity.
    J Med Chem. 1993 Dec 10;36(25):4069-74 PMID: 8258829
  12. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
    Proteins. 1993 Jul;16(3):226-45 PMID: 8346190
  13. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
    Mol Pharmacol. 1993 Sep;44(3):633-41 PMID: 8371715
  14. What determines the strength of noncovalent association of ligands to proteins in aqueous solution?
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8402-6 PMID: 8378312
  15. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):80-4 PMID: 8419946
  16. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
    J Med Chem. 1996 Jan 19;39(2):388-91 PMID: 8558506
  17. A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease.
    J Med Chem. 1996 Jan 19;39(2):392-7 PMID: 8558507
  18. A fast flexible docking method using an incremental construction algorithm.
    J Mol Biol. 1996 Aug 23;261(3):470-89 PMID: 8780787
  19. New series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors.
    J Med Chem. 1996 Aug 30;39(18):3431-4 PMID: 8784440
  20. Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.
    J Med Chem. 1996 Aug 30;39(18):3514-25 PMID: 8784449
  21. HIV protease inhibitory bis-benzamide cyclic ureas: a quantitative structure-activity relationship analysis.
    J Med Chem. 1996 Oct 11;39(21):4299-312 PMID: 8863807
  22. Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.
    J Med Chem. 1996 Oct 25;39(22):4349-53 PMID: 8893827
  23. Discovering high-affinity ligands for proteins: SAR by NMR.
    Science. 1996 Nov 29;274(5292):1531-4 PMID: 8929414
  24. Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.
    J Med Chem. 1996 Nov 22;39(24):4692-703 PMID: 8941382
  25. 5-HT1D receptor agonist properties of novel 2-[5-[[(trifluoromethyl)sulfonyl]oxy]indolyl]ethylamines and their use as synthetic intermediates.
    J Med Chem. 1996 Nov 22;39(24):4717-26 PMID: 8941384
  26. [125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistribution.
    J Med Chem. 1996 Nov 22;39(24):4804-9 PMID: 8941394
  27. Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis.
    J Med Chem. 1996 Nov 22;39(24):4825-32 PMID: 8941396
  28. Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists.
    J Med Chem. 1996 Dec 6;39(25):4867-70 PMID: 8960544
  29. Development of potent thrombin receptor antagonist peptides.
    J Med Chem. 1996 Dec 6;39(25):4879-87 PMID: 8960546
  30. Anti-inflammatory 17beta-thioalkyl-16alpha,17alpha-ketal and -acetal androstanes: a new class of airway selective steroids for the treatment of asthma.
    J Med Chem. 1996 Dec 6;39(25):4888-96 PMID: 8960547
  31. Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists.
    J Med Chem. 1996 Dec 6;39(25):4920-7 PMID: 8960551
  32. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    J Med Chem. 1996 Dec 6;39(25):4935-41 PMID: 8960553
  33. Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.
    J Med Chem. 1996 Dec 20;39(26):5072-82 PMID: 8978838
  34. Additivity principles in biochemistry.
    J Biol Chem. 1997 Jan 10;272(2):701-4 PMID: 8995351
  35. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.
    Chem Biol. 1997 Apr;4(4):297-307 PMID: 9195867
  36. Design of potent selective zinc-mediated serine protease inhibitors.
    Nature. 1998 Feb 5;391(6667):608-12 PMID: 9468142
  37. Computation of electrostatic complements to proteins: a case of charge stabilized binding.
    Protein Sci. 1998 Jan;7(1):206-10 PMID: 9514276
  38. Surface topography dependence of biomolecular hydrophobic hydration.
    Nature. 1998 Apr 16;392(6677):696-9 PMID: 9565030
  39. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?
    J Med Chem. 1998 Aug 27;41(18):3314-24 PMID: 9719583
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1999-08-31
Pages
9997-10002
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC17830
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com